ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
Dow Jones
38,711.29
0.36%
US Dollar vs MXN
17.87143
0.95%
Brent Oil
77.44
-0.90%
Bitcoin
70,307.27
2.18%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
04/06/202415:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSHCognizant Technology Solutions Corporation
04/06/202415:38Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXZiPath Series B S&P 500 VIX MidTerm Futures ETN
04/06/202415:38GlobeNewswire Inc.Pennsylvania SFI Implementation Committee Wins Award for Collaborating to Advance Conservation and Outreach
04/06/202415:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ELEstee Lauder Companies Inc
04/06/202415:37Edgar (US Regulatory)Form 8-K - Current reportNYSE:MDTMedtronic PLC
04/06/202415:37Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FUSNFusion Pharmaceuticals Inc
04/06/202415:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:BSACBanco Santander Chile
04/06/202415:36Business WireNorthwell Health and NY Attorney General Letitia James Enter Into Best Practices Agreement For Hospital Financial Assistance and Medical Debt Collection Policies
04/06/202415:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VSACWVision Sensing Acquisition Corporation
04/06/202415:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MFINMedallion Financial Corporation
04/06/202415:35Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FRMEPFirst Merchants Corporation
04/06/202415:35PR Newswire (US)Engage Check-In Revolutionizes Student Attendance by Engaging Parents
04/06/202415:35PR Newswire (US)AffableBPM names Greg Chavers as new Chief Revenue & Sales Officer to drive innovation in healthcare automation
04/06/202415:35GlobeNewswire Inc.Vision Sensing Acquisition Corp. Announces Receipt of a Deficiency Notice from Nasdaq for Failure to Timely File its 1st Quarter 2024 Form 10-Q and Announces the Filing of the Form 10-QNASDAQ:VSACUVision Sensing Acquisition Corporation
04/06/202415:34Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RGPResources Connection Inc
04/06/202415:33PR Newswire (US)DR. PHIL'S EXCLUSIVE INTERVIEW WITH DONALD TRUMP TO AIR ON MERIT STREET MEDIA™ THURSDAY, JUNE 6
04/06/202415:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FUSNFusion Pharmaceuticals Inc
04/06/202415:31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:LRHCLa Rosa Holdings Corporation
04/06/202415:30GlobeNewswire Inc.CORRECTION - OTC Markets Group Welcomes Verde Agritech Ltd. to OTCQXNPK.TO
04/06/202415:30GlobeNewswire Inc.Lifeward to Present at Sidoti Virtual Investor Conference on June 12NASDAQ:LFWDReWalk Robotics Ltd
04/06/202415:30Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]USOTC:NVSEFNovartis Ag Basel Namen Akt (PK)
04/06/202415:30Edgar (US Regulatory)Form CERT - Certification by an exchange approving securities for listingNASDAQ:WBDWarner Brothers Discovery Inc
04/06/202415:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BETRWBetter Home and Finance Holding Company
04/06/202415:30GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024EU:DBVDBV Technologies
04/06/202415:30Business WireInfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024AMEX:INFUInfuSystems Holdings Inc
04/06/202415:30GlobeNewswire Inc.LanzaTech to Participate in Upcoming Investor EventsNASDAQ:LNZALanzaTech Global Inc
04/06/202415:30GlobeNewswire Inc.Cellectis obtient la désignation de médicament orphelin pour son produit CAR T allogénique UCART22 pour les patients atteints de leucémie lymphoblastique aiguëEU:ALCLSCellectis Nom Eo 05
04/06/202415:30Business WireJohnson & Johnson to Host Investor Conference Call on Second-Quarter ResultsNYSE:JNJJohnson and Johnson
04/06/202415:30GlobeNewswire Inc.Host Hotels & Resorts Announces Second Quarter 2024 Earnings Call to be Held on August 1, 2024NASDAQ:HSTHost Hotels and Resorts Inc
04/06/202415:30GlobeNewswire Inc.Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic LeukemiaTG:ZVACellectis Nom Eo 05

Su Consulta Reciente

ASX
KLL
Kalium Lakes
LSE
SG21
Morg.st.b.v 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados